Sunmax Business Summary

Sunmax Biotechnology Co., Ltd. (4728.TWO) operates a vertically integrated biomedical business model, generating revenue through the research, development, and commercialization of high-purity atelo-collagen medical devices and skincare products. The company’s primary business is divided into four segments: aesthetic dermal fillers (notably the Sunmax FACIALGAIN and Deusaderm series), dental biomaterials (including collagen bone grafts and resorbable membranes), orthopedic bone void fillers, and collagen-based skincare aftercare solutions. Sunmax maintains a dominant market position in Taiwan and Mainland China as a pioneer in collagen-based aesthetics, leveraging its proprietary extraction technology to achieve industry-leading gross margins exceeding 78%. Its primary direct competitors include Maxigen Biotech Inc. (1783.TWO), Ever Supreme Bio Technology Co., Ltd. (6712.TWO), and Bonraybio Co., Ltd. (6955.TWO), against whom Sunmax differentiates itself through its unique regulatory status as a long-standing collagen implant license holder in the Chinese market and its aggressive expansion into ASEAN territories like Thailand and Singapore. Founded in 2001 with core technology derived from United States-based collagen experts, Sunmax is currently led by CEO Ming Yi Lin, CTO Yu Te Lin, and Chairman Barry Lin (Lin Qi-Guo), who oversees the firm’s strategic direction and manufacturing scaling, including the development of a new high-capacity facility slated for full production in 2027. The leadership team is supported by a board that includes prominent industry figures such as Cai Guo-Jhou, the founder of the Ginko International Group, which became a major strategic investor and parent group in 2016. This pedigree combines deep technical expertise in porcine collagen purification with the commercial scale of the Ginko Group, a global leader in the optical and healthcare sectors. The executive team’s focus remains on high-barrier-to-entry regenerative materials, supported by a robust portfolio of international patents and GMP-certified facilities in the Tainan Science Industrial Park.